Povetacicept
( DrugBank: Povetacicept / KEGG DRUG: Povetacicept )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
61 | Autoimmune hemolytic anemia | 1 |
63 | Idiopathic thrombocytopenic purpura | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
222 | Primary nephrotic syndrome | 1 |
61. Autoimmune hemolytic anemia
Clinical trials : 183 / Drugs : 119 - (DrugBank : 42) / Drug target genes : 31 - Drug target pathways : 156
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
63. Idiopathic thrombocytopenic purpura
Clinical trials : 575 / Drugs : 261 - (DrugBank : 64) / Drug target genes : 61 - Drug target pathways : 142
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
222. Primary nephrotic syndrome
Clinical trials : 382 / Drugs : 278 - (DrugBank : 98) / Drug target genes : 73 - Drug target pathways : 197
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|